{"id":824369,"date":"2025-03-11T10:04:49","date_gmt":"2025-03-11T14:04:49","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/biofrontera-inc-to-report-fourth-quarter-and-full-year-2024-financial-results-on-march-21-2025\/"},"modified":"2025-03-11T10:04:49","modified_gmt":"2025-03-11T14:04:49","slug":"biofrontera-inc-to-report-fourth-quarter-and-full-year-2024-financial-results-on-march-21-2025","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/biofrontera-inc-to-report-fourth-quarter-and-full-year-2024-financial-results-on-march-21-2025\/","title":{"rendered":"Biofrontera Inc. to Report Fourth Quarter and Full Year 2024 Financial Results on March 21, 2025"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">\n        <strong>WOBURN, Mass., March  11, 2025  (GLOBE NEWSWIRE) &#8212; Biofrontera Inc. (NASDAQ:BFRI),<\/strong>\u00a0a biopharmaceutical company specializing in the development and commercialization of dermatological products, today announced that it will report financial results for the three and 12 months ended December 31, 2024 on Friday, March 21, 2025. The results will be released before the market opens on Friday, March 21 and the company will host a conference call on Friday, March 21 at 10:00am Eastern Time.<\/p>\n<p align=\"justify\">\n        <strong>Conference Call and Webcast Information<\/strong>\n      <\/p>\n<table style=\"border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;border-collapse: collapse;width:100%;border-collapse:collapse\">\n<tr>\n<td style=\"border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;text-align: justify;vertical-align: middle;vertical-align: top\">Date<\/td>\n<td style=\"border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;text-align: justify;vertical-align: middle;vertical-align: top\">\n            <strong>Friday, March 21, 2025<\/strong>\n          <\/td>\n<\/tr>\n<tr>\n<td style=\"border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;text-align: justify;vertical-align: middle;vertical-align: top\">Time<\/td>\n<td style=\"border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;text-align: justify;vertical-align: middle;vertical-align: top\">\n            <strong>10:00 AM Eastern Time<\/strong>\n          <\/td>\n<\/tr>\n<tr>\n<td style=\"border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;text-align: justify;vertical-align: middle;vertical-align: top\">Dial In Numbers<\/td>\n<td style=\"border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;text-align: justify;vertical-align: middle;vertical-align: top\">\n            <strong>1-877-877-1275 (U.S.)<\/strong><br \/>\n            <br \/>\n            <strong>1-412-858-5202 (international)<\/strong>\n          <\/td>\n<\/tr>\n<tr>\n<td style=\"border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;text-align: justify;vertical-align: middle;vertical-align: top\">Webcast<\/td>\n<td style=\"border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;text-align: justify;vertical-align: middle;vertical-align: top\">\n            <a href=\"https:\/\/event.choruscall.com\/mediaframe\/webcast.html?webcastid=mOwS4ULk\" rel=\"nofollow\" target=\"_blank\"><br \/>\n              <strong><br \/>\n                <u>Fourth Quarter and FY 2024 Financial Results and Business Update Conference Call<\/u><br \/>\n              <\/strong><br \/>\n            <\/a>\n          <\/td>\n<\/tr>\n<\/table>\n<p align=\"justify\">\n        <strong><br \/>\n          <br \/>About Biofrontera Inc.<\/strong>\n      <\/p>\n<p align=\"justify\">Biofrontera Inc. is a U.S.-based biopharmaceutical company specializing in the development and treatment of dermatological conditions with a focus on PDT. The Company commercializes the drug-device combination Ameluz<sup>\u00ae<\/sup>\u00a0with the RhodoLED<sup>\u00ae<\/sup>\u00a0lamp series for PDT of AK, pre-cancerous skin lesions which may progress to invasive skin cancers. The Company performs clinical trials to extend the use of the products to treat non-melanoma skin cancers and moderate to severe acne. For more information, visit\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=4wvujwhAIVZvuQi8ERQDTaW4IMpu0dlArHS6Dv4fCVu07njaDasmiX0rCkV4MRVLKS8od-f2am2QXO0pxJ8Tcvv0lH4fJvirBoccV9vs-j6UFKve99qc4M5DFywqHqJM\" rel=\"nofollow\" target=\"_blank\"><u>www.biofrontera-us.com\u00a0<\/u><\/a>and follow Biofrontera on\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=r3eanaMicbRv09I5EswBBfJeggqF9oc2m1CG8oiPv1eQ8Ise_hslSCe2-yAphUxKXsIgg5VZC4vRiHMxy5COUH5IhVfeeZbhxJYuOfBrmDOmYqIcWMSjMtADZJAzaUQxNz_G8x-nse-_dpJJc531yId4Z1XBcfmyP3RK0PaWqFlyhMcV4NRf2ApKDTKYZKFGGkkyoTBRA0o638wn6H3PACEHG1jhAprj9Zc9SpFNE34C35ZLJqIYXkeGD7vIiv0p2sNu29M8_cFVl1b47azh5Q==\" rel=\"nofollow\" target=\"_blank\"><u>LinkedIn<\/u><\/a> and\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Q27GDYlyUf7gDEVJhJUWofTie-Okoj8Zo38CL8xsBx9CnSgwaUYhhD3iy4eiyfMddEEmgWJxyIzMj7UhzlKT6jaq5ovqoUeCcyIQeWRFTEVBf0I4l-fOdQcZXNCwQrOxBDuUdj2O2OV5kX-kQpV4tB1wQw_FSFepM-L0S1RvTxNuMDsk5EG97ip1TDNXUBxYAERnLMZccDzL7LzdN1knr-pAD4jii2_WUCaWzT0sbKgEe6WhWmsFjLafoOLKGiLI\" rel=\"nofollow\" target=\"_blank\"><u>X<\/u><\/a>.<\/p>\n<p>\n        <strong>Contacts:<\/strong><br \/>\n        <br \/>Investor Relations<br \/>Andrew Barwicki<br \/>1-516-662-9461<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=N0eilbgUWJn7h3Lef3NkrYpPpIGWG-hIdynIiy9n-Dk6i8rXg4IPxEvaCtm-Owcom83gQH-rPxDPnvsxQkpUpQ==\" rel=\"nofollow\" target=\"_blank\"><u>ir@bfri.com<\/u><\/a><\/p>\n<p>\n        <strong>SOURCE:\u00a0<\/strong>Biofrontera Inc.<\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM5MjU1MCM2ODAwNjk2IzUwMDA4NTk2Mw==\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/ZGFmMjY3MzktNDVkMi00N2ExLTlhZTctOGRiNWJmYTY0NGE5LTUwMDA4NTk2My0yMDI1LTAzLTExLWVu\/tiny\/Biofrontera-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>WOBURN, Mass., March 11, 2025 (GLOBE NEWSWIRE) &#8212; Biofrontera Inc. (NASDAQ:BFRI),\u00a0a biopharmaceutical company specializing in the development and commercialization of dermatological products, today announced that it will report financial results for the three and 12 months ended December 31, 2024 on Friday, March 21, 2025. The results will be released before the market opens on Friday, March 21 and the company will host a conference call on Friday, March 21 at 10:00am Eastern Time. Conference Call and Webcast Information Date Friday, March 21, 2025 Time 10:00 AM Eastern Time Dial In Numbers 1-877-877-1275 (U.S.) 1-412-858-5202 (international) Webcast Fourth Quarter and FY 2024 Financial Results and Business Update Conference Call About Biofrontera Inc. Biofrontera Inc. is a U.S.-based biopharmaceutical company specializing &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/biofrontera-inc-to-report-fourth-quarter-and-full-year-2024-financial-results-on-march-21-2025\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Biofrontera Inc. to Report Fourth Quarter and Full Year 2024 Financial Results on March 21, 2025&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-824369","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Biofrontera Inc. to Report Fourth Quarter and Full Year 2024 Financial Results on March 21, 2025 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/biofrontera-inc-to-report-fourth-quarter-and-full-year-2024-financial-results-on-march-21-2025\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Biofrontera Inc. to Report Fourth Quarter and Full Year 2024 Financial Results on March 21, 2025 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"WOBURN, Mass., March 11, 2025 (GLOBE NEWSWIRE) &#8212; Biofrontera Inc. (NASDAQ:BFRI),\u00a0a biopharmaceutical company specializing in the development and commercialization of dermatological products, today announced that it will report financial results for the three and 12 months ended December 31, 2024 on Friday, March 21, 2025. The results will be released before the market opens on Friday, March 21 and the company will host a conference call on Friday, March 21 at 10:00am Eastern Time. Conference Call and Webcast Information Date Friday, March 21, 2025 Time 10:00 AM Eastern Time Dial In Numbers 1-877-877-1275 (U.S.) 1-412-858-5202 (international) Webcast Fourth Quarter and FY 2024 Financial Results and Business Update Conference Call About Biofrontera Inc. Biofrontera Inc. is a U.S.-based biopharmaceutical company specializing &hellip; Continue reading &quot;Biofrontera Inc. to Report Fourth Quarter and Full Year 2024 Financial Results on March 21, 2025&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/biofrontera-inc-to-report-fourth-quarter-and-full-year-2024-financial-results-on-march-21-2025\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-03-11T14:04:49+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM5MjU1MCM2ODAwNjk2IzUwMDA4NTk2Mw==\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biofrontera-inc-to-report-fourth-quarter-and-full-year-2024-financial-results-on-march-21-2025\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biofrontera-inc-to-report-fourth-quarter-and-full-year-2024-financial-results-on-march-21-2025\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Biofrontera Inc. to Report Fourth Quarter and Full Year 2024 Financial Results on March 21, 2025\",\"datePublished\":\"2025-03-11T14:04:49+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biofrontera-inc-to-report-fourth-quarter-and-full-year-2024-financial-results-on-march-21-2025\\\/\"},\"wordCount\":217,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biofrontera-inc-to-report-fourth-quarter-and-full-year-2024-financial-results-on-march-21-2025\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM5MjU1MCM2ODAwNjk2IzUwMDA4NTk2Mw==\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biofrontera-inc-to-report-fourth-quarter-and-full-year-2024-financial-results-on-march-21-2025\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biofrontera-inc-to-report-fourth-quarter-and-full-year-2024-financial-results-on-march-21-2025\\\/\",\"name\":\"Biofrontera Inc. to Report Fourth Quarter and Full Year 2024 Financial Results on March 21, 2025 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biofrontera-inc-to-report-fourth-quarter-and-full-year-2024-financial-results-on-march-21-2025\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biofrontera-inc-to-report-fourth-quarter-and-full-year-2024-financial-results-on-march-21-2025\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM5MjU1MCM2ODAwNjk2IzUwMDA4NTk2Mw==\",\"datePublished\":\"2025-03-11T14:04:49+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biofrontera-inc-to-report-fourth-quarter-and-full-year-2024-financial-results-on-march-21-2025\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biofrontera-inc-to-report-fourth-quarter-and-full-year-2024-financial-results-on-march-21-2025\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biofrontera-inc-to-report-fourth-quarter-and-full-year-2024-financial-results-on-march-21-2025\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM5MjU1MCM2ODAwNjk2IzUwMDA4NTk2Mw==\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM5MjU1MCM2ODAwNjk2IzUwMDA4NTk2Mw==\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biofrontera-inc-to-report-fourth-quarter-and-full-year-2024-financial-results-on-march-21-2025\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Biofrontera Inc. to Report Fourth Quarter and Full Year 2024 Financial Results on March 21, 2025\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Biofrontera Inc. to Report Fourth Quarter and Full Year 2024 Financial Results on March 21, 2025 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/biofrontera-inc-to-report-fourth-quarter-and-full-year-2024-financial-results-on-march-21-2025\/","og_locale":"en_US","og_type":"article","og_title":"Biofrontera Inc. to Report Fourth Quarter and Full Year 2024 Financial Results on March 21, 2025 - Market Newsdesk","og_description":"WOBURN, Mass., March 11, 2025 (GLOBE NEWSWIRE) &#8212; Biofrontera Inc. (NASDAQ:BFRI),\u00a0a biopharmaceutical company specializing in the development and commercialization of dermatological products, today announced that it will report financial results for the three and 12 months ended December 31, 2024 on Friday, March 21, 2025. The results will be released before the market opens on Friday, March 21 and the company will host a conference call on Friday, March 21 at 10:00am Eastern Time. Conference Call and Webcast Information Date Friday, March 21, 2025 Time 10:00 AM Eastern Time Dial In Numbers 1-877-877-1275 (U.S.) 1-412-858-5202 (international) Webcast Fourth Quarter and FY 2024 Financial Results and Business Update Conference Call About Biofrontera Inc. Biofrontera Inc. is a U.S.-based biopharmaceutical company specializing &hellip; Continue reading \"Biofrontera Inc. to Report Fourth Quarter and Full Year 2024 Financial Results on March 21, 2025\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/biofrontera-inc-to-report-fourth-quarter-and-full-year-2024-financial-results-on-march-21-2025\/","og_site_name":"Market Newsdesk","article_published_time":"2025-03-11T14:04:49+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM5MjU1MCM2ODAwNjk2IzUwMDA4NTk2Mw==","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biofrontera-inc-to-report-fourth-quarter-and-full-year-2024-financial-results-on-march-21-2025\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biofrontera-inc-to-report-fourth-quarter-and-full-year-2024-financial-results-on-march-21-2025\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Biofrontera Inc. to Report Fourth Quarter and Full Year 2024 Financial Results on March 21, 2025","datePublished":"2025-03-11T14:04:49+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biofrontera-inc-to-report-fourth-quarter-and-full-year-2024-financial-results-on-march-21-2025\/"},"wordCount":217,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biofrontera-inc-to-report-fourth-quarter-and-full-year-2024-financial-results-on-march-21-2025\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM5MjU1MCM2ODAwNjk2IzUwMDA4NTk2Mw==","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biofrontera-inc-to-report-fourth-quarter-and-full-year-2024-financial-results-on-march-21-2025\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/biofrontera-inc-to-report-fourth-quarter-and-full-year-2024-financial-results-on-march-21-2025\/","name":"Biofrontera Inc. to Report Fourth Quarter and Full Year 2024 Financial Results on March 21, 2025 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biofrontera-inc-to-report-fourth-quarter-and-full-year-2024-financial-results-on-march-21-2025\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biofrontera-inc-to-report-fourth-quarter-and-full-year-2024-financial-results-on-march-21-2025\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM5MjU1MCM2ODAwNjk2IzUwMDA4NTk2Mw==","datePublished":"2025-03-11T14:04:49+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biofrontera-inc-to-report-fourth-quarter-and-full-year-2024-financial-results-on-march-21-2025\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/biofrontera-inc-to-report-fourth-quarter-and-full-year-2024-financial-results-on-march-21-2025\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biofrontera-inc-to-report-fourth-quarter-and-full-year-2024-financial-results-on-march-21-2025\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM5MjU1MCM2ODAwNjk2IzUwMDA4NTk2Mw==","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM5MjU1MCM2ODAwNjk2IzUwMDA4NTk2Mw=="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biofrontera-inc-to-report-fourth-quarter-and-full-year-2024-financial-results-on-march-21-2025\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Biofrontera Inc. to Report Fourth Quarter and Full Year 2024 Financial Results on March 21, 2025"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/824369","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=824369"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/824369\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=824369"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=824369"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=824369"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}